Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Vladimir J. Lozanovski is active.

Publication


Featured researches published by Vladimir J. Lozanovski.


American Journal of Human Genetics | 2012

Copy-Number Disorders Are a Common Cause of Congenital Kidney Malformations

Simone Sanna-Cherchi; Krzysztof Kiryluk; Katelyn E. Burgess; Monica Bodria; Matthew Sampson; Dexter Hadley; Shannon N. Nees; Miguel Verbitsky; Brittany J. Perry; Roel Sterken; Vladimir J. Lozanovski; Anna Materna-Kiryluk; Cristina Barlassina; Akshata Kini; Valentina Corbani; Alba Carrea; Danio Somenzi; Corrado Murtas; Nadica Ristoska-Bojkovska; Claudia Izzi; Beatrice Bianco; Marcin Zaniew; Hana Flögelová; Patricia L. Weng; Nilgun Kacak; Stefania Giberti; Maddalena Gigante; Adela Arapović; Kristina Drnasin; Gianluca Caridi

We examined the burden of large, rare, copy-number variants (CNVs) in 192 individuals with renal hypodysplasia (RHD) and replicated findings in 330 RHD cases from two independent cohorts. CNV distribution was significantly skewed toward larger gene-disrupting events in RHD cases compared to 4,733 ethnicity-matched controls (p = 4.8 × 10(-11)). This excess was attributable to known and novel (i.e., not present in any database or in the literature) genomic disorders. All together, 55/522 (10.5%) RHD cases harbored 34 distinct known genomic disorders, which were detected in only 0.2% of 13,839 population controls (p = 1.2 × 10(-58)). Another 32 (6.1%) RHD cases harbored large gene-disrupting CNVs that were absent from or extremely rare in the 13,839 population controls, identifying 38 potential novel or rare genomic disorders for this trait. Deletions at the HNF1B locus and the DiGeorge/velocardiofacial locus were most frequent. However, the majority of disorders were detected in a single individual. Genomic disorders were detected in 22.5% of individuals with multiple malformations and 14.5% of individuals with isolated urinary-tract defects; 14 individuals harbored two or more diagnostic or rare CNVs. Strikingly, the majority of the known CNV disorders detected in the RHD cohort have previous associations with developmental delay or neuropsychiatric diseases. Up to 16.6% of individuals with kidney malformations had a molecular diagnosis attributable to a copy-number disorder, suggesting kidney malformations as a sentinel manifestation of pathogenic genomic imbalances. A search for pathogenic CNVs should be considered in this population for the diagnosis of their specific genomic disorders and for the evaluation of the potential for developmental delay.


The New England Journal of Medicine | 2013

Mutations in DSTYK and Dominant Urinary Tract Malformations

Simone Sanna-Cherchi; R.V. Sampogna; Natalia Papeta; Katelyn E. Burgess; Shannon N. Nees; Brittany J. Perry; Murim Choi; Monica Bodria; Yuanli Liu; Patricia L. Weng; Vladimir J. Lozanovski; Miguel Verbitsky; F. Lugani; Roel Sterken; Neal Paragas; Gianluca Caridi; Alba Carrea; M. Dagnino; Anna Materna-Kiryluk; G. Santamaria; C. Murtas; Nadica Ristoska-Bojkovska; Claudia Izzi; Nilgun Kacak; Beatrice Bianco; S. Giberti; Maddalena Gigante; G. Piaggio; Loreto Gesualdo; D. Kosuljandic Vukic

BACKGROUND Congenital abnormalities of the kidney and the urinary tract are the most common cause of pediatric kidney failure. These disorders are highly heterogeneous, and the etiologic factors are poorly understood. METHODS We performed genomewide linkage analysis and whole-exome sequencing in a family with an autosomal dominant form of congenital abnormalities of the kidney or urinary tract (seven affected family members). We also performed a sequence analysis in 311 unrelated patients, as well as histologic and functional studies. RESULTS Linkage analysis identified five regions of the genome that were shared among all affected family members. Exome sequencing identified a single, rare, deleterious variant within these linkage intervals, a heterozygous splice-site mutation in the dual serine-threonine and tyrosine protein kinase gene (DSTYK). This variant, which resulted in aberrant splicing of messenger RNA, was present in all affected family members. Additional, independent DSTYK mutations, including nonsense and splice-site mutations, were detected in 7 of 311 unrelated patients. DSTYK is highly expressed in the maturing epithelia of all major organs, localizing to cell membranes. Knockdown in zebrafish resulted in developmental defects in multiple organs, which suggested loss of fibroblast growth factor (FGF) signaling. Consistent with this finding is the observation that DSTYK colocalizes with FGF receptors in the ureteric bud and metanephric mesenchyme. DSTYK knockdown in human embryonic kidney cells inhibited FGF-stimulated phosphorylation of extracellular-signal-regulated kinase (ERK), the principal signal downstream of receptor tyrosine kinases. CONCLUSIONS We detected independent DSTYK mutations in 2.3% of patients with congenital abnormalities of the kidney or urinary tract, a finding that suggests that DSTYK is a major determinant of human urinary tract development, downstream of FGF signaling. (Funded by the National Institutes of Health and others.).


PLOS ONE | 2011

Clinical and Functional Characterization of URAT1 Variants

Velibor Tasic; Ann Marie Hynes; Hae Il Cheong; Vladimir J. Lozanovski; Zoran Gucev; Promsuk Jutabha; Naohiko Anzai; John A. Sayer

Idiopathic renal hypouricaemia is an inherited form of hypouricaemia, associated with abnormal renal handling of uric acid. There is excessive urinary wasting of uric acid resulting in hypouricaemia. Patients may be asymptomatic, but the persistent urinary abnormalities may manifest as renal stone disease, and hypouricaemia may manifest as exercise induced acute kidney injury. Here we have identified Macedonian and British patients with hypouricaemia, who presented with a variety of renal symptoms and signs including renal stone disease, hematuria, pyelonephritis and nephrocalcinosis. We have identified heterozygous missense mutations in SLC22A12 encoding the urate transporter protein URAT1 and correlate these genetic findings with functional characterization. Urate handling was determined using uptake experiments in HEK293 cells. This data highlights the importance of the URAT1 renal urate transporter in determining serum urate concentrations and the clinical phenotypes, including nephrolithiasis, that should prompt the clinician to suspect an inherited form of renal hypouricaemia.


PLOS ONE | 2014

Prediction of Postoperative Mortality in Liver Transplantation in the Era of MELD-Based Liver Allocation: A Multivariate Analysis

Helge Bruns; Vladimir J. Lozanovski; Daniel Schultze; Norbert Hillebrand; Ulf Hinz; Markus W. Büchler; Peter Schemmer

Background and Aims Liver transplantation is the only curative treatment for end-stage liver disease. While waiting list mortality can be predicted by the MELD-score, reliable scoring systems for the postoperative period do not exist. This studys objective was to identify risk factors that contribute to postoperative mortality. Methods Between December 2006 and March 2011, 429 patients underwent liver transplantation in our department. Risk factors for postoperative mortality in 266 consecutive liver transplantations were identified using univariate and multivariate analyses. Patients who were <18 years, HU-listings, and split-, living related, combined or re-transplantations were excluded from the analysis. The correlation between number of risk factors and mortality was analyzed. Results A labMELD ≥20, female sex, coronary heart disease, donor risk index >1.5 and donor Na+>145 mmol/L were identified to be independent predictive factors for postoperative mortality. With increasing number of these risk-factors, postoperative 90-day and 1-year mortality increased (0–1: 0 and 0%; 2: 2.9 and 17.4%; 3: 5.6 and 16.8%; 4: 22.2 and 33.3%; 5–6: 60.9 and 66.2%). Conclusions In this analysis, a simple score was derived that adequately identified patients at risk after liver transplantation. Opening a discussion on the inclusion of these parameters in the process of organ allocation may be a worthwhile venture.


Pediatric Nephrology | 2011

Clinical and laboratory features of Macedonian children with OCRL mutations

Velibor Tasic; Vladimir J. Lozanovski; Petar Korneti; Nadica Ristoska-Bojkovska; Vesna Sabolic-Avramovska; Zoran Gucev; Michael Ludwig

OCRL mutations, which are a hallmark of Lowe syndrome, have recently been found in patients with isolated renal phenotype (Dent-2 disease). In this report, we describe clinical and laboratory features in five Macedonian children with mutations in the OCRL gene. Children with a clinical diagnosis of Lowe syndrome or Dent disease underwent complete neurological and ophthalmological examination, imaging of the kidney and urinary tract, assessment of renal tubular function, and mutation analysis of the OCRL gene. Two children (18 months and 11 years, respectively) were diagnosed with Lowe syndrome on the basis of congenital cataracts, severe psychomotor retardation, and renal dysfunction. Both children had low molecular weight proteinuria (LMWP) and hypercalciuria, but not Fanconi syndrome. The older one had bilateral nephrolithiasis due to associated hypocitraturia and mild hyperoxaluria. Three children with asymptomatic proteinuria were diagnosed with Dent-2 disease; none had cataracts or neurological deficit. One child showed mild mental retardation. All had LMWP, hypercalciuria, and elevated enzymes (creatine phosphokinase, lactic dehydrogenase). All three children had an abnormal Tc-99m DMSA scan revealing poor visualization of the kidneys with a high radionuclide content in the bladder; none had nephrolithiasis or nephrocalcinosis. In conclusion, children with OCRL mutations may present with very mild phenotype (asymptomatic proteinuria with/without mild mental retardation) or severe classic oculocerebrorenal syndrome of Lowe. Elevated enzymes and abnormal results on the Tc-99m DMSA scan may be useful indicators for Dent-2 disease.


Journal of The American College of Surgeons | 2013

Teres Hepatis Ligament Flap Plasty to Prevent Pancreatic Fistula after Tumor Enucleation

Thilo Hackert; Vladimir J. Lozanovski; Jens Werner; Markus W. Büchler; Peter Schemmer

Due to the rapid technical progresswith development of high quality imaging tools, incidental diagnosis of small pancreatic lesionsdincluding cystic and solid pathologiesdhas significantly increased in recent years. Besides solid tumors (eg, small neuroendocrine tumors), especially small cystic lesions (eg, side-branch intraductal papillary mucinous neoplasms) bear a relevant risk of malignant transformation. Therefore, surgical management is required for a considerable proportion of these findings. Because these often premalignant lesions do not necessarily require radical oncologic resection, parenchyma-sparing resections have been accepted as surgical standards, among them tumor enucleation (TE) for lesions not exceeding a diameter of 2 cm and lacking signs of malignancy. These techniques offer maximum pancreatic tissue preservation to avoid exocrine and endocrine insufficiencies, which are observed in a considerable number of patients after standard procedures such as pancreaticoduodenectomy or distal pancreatectomy. Postoperative pancreatic fistula (POPF) has been reported as the most frequent complication after TE, with a reported rate between 18% and 50%. Although POPFs after TE are mainly uncomplicated (mostly International Study Group on Pancreatic Fistula [ISGPF] grade A), they remain an unsolved and potentially long-lasting clinical problem. The versatility of the teres hepatis ligament and its use as a surgical cover structure has been described in various procedures, including filling of liver defects after hydatid cysts resection in order to prevent bile leakage, covering the gastroduodenal artery stump during pancreaticoduodenectomy, and covering the resection margin after distal pancreatectomy to prevent leakage. To our knowledge, there have been no reports on teres hepatis


World Journal of Pediatrics | 2011

OCRL1 mutation in a boy with Dent disease, mild mental retardation, but without cataracts

Vladimir J. Lozanovski; Nadica Ristoska-Bojkovska; Petar Korneti; Zoran Gucev; Velibor Tasic

BackgroundOculocerebrorenal (Lowe) syndrome is an X-linked multisystem disease characterized by renal proximal tubulopathy, mental retardation, and congenital cataracts. We present a 19-year-old boy who was found to have low molecular weight proteinuria, hypercalciuria, mild generalized hyperaminoaciduria and intermittent microscopic hematuria at the age of 3.MethodsStandard clinical and biochemical examinations and mutational analysis of the CLNC5 and OCRL1 gene were performed for the patient.ResultsThe patient fulfilled diagnostic criteria for Dent disease, but lacked mutation in CLCN5. Sequencing of candidate genes revealed a mutation in his OCRL1 gene, which encodes for enzyme PIP2 5-phosphatase. The enzyme was not detected by western blot analysis, and decreased activity of the enzyme PIP2 5-phosphatase was observed in cultured skin fibroblasts. The boy had only mild mental retardation, mildly elevated muscle enzymes, but no neurological deficit or congenital cataracts, which are typical for Lowe syndrome.ConclusionsChildren with Dent phenotype who lack CLCN5 mutation should be tested for OCRL1 mutation. OCRL1 mutations may present with mild clinical features and are not necessarily associated with congenital cataracts.


Nature Communications | 2017

Blood vessel control of macrophage maturation promotes arteriogenesis in ischemia

Kashyap Krishnasamy; Anne Limbourg; Tamar Kapanadze; Jaba Gamrekelashvili; Christian Beger; Christine Haeger; Vladimir J. Lozanovski; Christine S. Falk; L. Christian Napp; Johann Bauersachs; Matthias Mack; Hermann Haller; Christian Weber; Ralf H. Adams; Florian P. Limbourg

Ischemia causes an inflammatory response that is intended to restore perfusion and homeostasis yet often aggravates damage. Here we show, using conditional genetic deletion strategies together with adoptive cell transfer experiments in a mouse model of hind limb ischemia, that blood vessels control macrophage differentiation and maturation from recruited monocytes via Notch signaling, which in turn promotes arteriogenesis and tissue repair. Macrophage maturation is controlled by Notch ligand Dll1 expressed in vascular endothelial cells of arteries and requires macrophage canonical Notch signaling via Rbpj, which simultaneously suppresses an inflammatory macrophage fate. Conversely, conditional mutant mice lacking Dll1 or Rbpj show proliferation and transient accumulation of inflammatory macrophages, which antagonizes arteriogenesis and tissue repair. Furthermore, the effects of Notch are sufficient to generate mature macrophages from monocytes ex vivo that display a stable anti-inflammatory phenotype when challenged with pro-inflammatory stimuli. Thus, angiocrine Notch signaling fosters macrophage maturation during ischemia.Molecular mechanisms of macrophage-mediated regulation of artery growth in response to ischemia are poorly understood. Here the authors show that vascular endothelium controls macrophage maturation and differentiation via Notch signaling, which in turn promotes arteriogenesis and ischemic tissue recovery.


Pediatric Nephrology | 2011

Failure to thrive and nephrolithiasis in a boy with congenital cyanotic heart anomaly—questions

Velibor Tasic; Vladimir J. Lozanovski; Zoran Gucev; Nenad Blau; Hae Il Cheong; John A. Sayer

Case summary A 3-year-old boy from Kosovo was referred to us for evaluation of failure to thrive and an episode of macro


European Journal of Pediatrics | 2011

Nephrotic syndrome occurring during tiopronin treatment for cystinuria

Velibor Tasic; Vladimir J. Lozanovski; Nadica Ristoska-Bojkovska; Emilija Sahpazova; Zoran Gucev

Collaboration


Dive into the Vladimir J. Lozanovski's collaboration.

Top Co-Authors

Avatar

Velibor Tasic

Boston Children's Hospital

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Zoran Gucev

Boston Children's Hospital

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge